Neuroprotection by the cannabidiol aminoquinone VCE-004.8 in experimental ischemic stroke in mice
- 28 February 2023
- journal article
- research article
- Published by Elsevier in Neurochemistry International
- Vol. 165, 105508
Abstract
No abstract availableKeywords
Funding Information
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (88887.682343/2022–00)
This publication has 41 references indexed in Scilit:
- Delayed Administration of Interleukin-1 Receptor Antagonist Reduces Ischemic Brain Damage and Inflammation in Comorbid RatsJournal of Cerebral Blood Flow & Metabolism, 2012
- Cannabinoid Type 2 Receptor Activation Downregulates Stroke-Induced Classic and Alternative Brain Macrophage/Microglial Activation Concomitant to NeuroprotectionStroke, 2012
- The immunology of stroke: from mechanisms to translationNature Medicine, 2011
- Peroxisome-proliferator-activated receptors γ and peroxisome-proliferator-activated receptors β/δ and the regulation of interleukin 1 receptor antagonist expression by pioglitazone in ischaemic brainJournal Of Hypertension, 2010
- Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitmentThe FASEB Journal, 2009
- Neuronal PPARγ Deficiency Increases Susceptibility to Brain Damage after Cerebral IschemiaJournal of Neuroscience, 2009
- Synthesis of Lipoxin A4by 5-Lipoxygenase Mediates PPARγ-Dependent, Neuroprotective Effects of Rosiglitazone in Experimental StrokeJournal of Neuroscience, 2009
- The single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction: twenty-something years onNature Protocols, 2006
- Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemiaAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- A Peroxisome Proliferator-Activated Receptor-γ Agonist Reduces Infarct Size in Transient but Not in Permanent IschemiaStroke, 2005